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doi:10.1016/j.jtcvs.2006.06.034bjectives: We sought to examine risk factors for pulmonary conduit failu
ysfunction in infants less than age 2 years at initial implantation.
ethods: From 2002 to 2005, 241 children at 17 institutions were discharged
fter initial pulmonary conduit insertion. Initial conduit type was pulmonary
raft in 37%, aortic allograft in 29%, bovine jugular venous valved conduit i
orcine heterograft in 2%, and decellularized allograft in 7%. Parametric h
nalysis determined time-related prevalence and associated risk factors for pu
ary conduit intervention and explantation. Serial echocardiographic measurem
fter conduit implant were analyzed by mixed regression models.
esults: There were 89 first conduit-related interventions after discharge an
ntial conduit explants were performed. First conduit intervention occurred 
onstant rate, with a prevalence of 58% at 3 years from initial implant. Pul
onduit explantation (30% at 3 years) was characterized by an early-rising
uggesting that catheter-based intervention effectively blunts this early initial 
ommon risk-factors for first conduit intervention and explantation were sm
onduit Z-score and younger age at initial conduit implant, and the prese
ulmonary arborization abnormalities or stenoses. Pulmonary conduit peak grad
nd regurgitation progressed nonlinearly in all patients over time. Gradient
ressed more rapidly in children with aortic allografts and when initial c
-score was less than 1 or more than 3. Pulmonary conduit regurgitation al
rogressed more rapidly in children with initial conduit Z-score greater than 3 and
n those without jugular venous valved conduits, especially aortic allografts.
onclusions: Pulmonary conduit durability and hemodynamic function in pati
ndergoing initial conduit insertion at less than age 2 years can be impro
sing pulmonary conduits with Z-scores between 1 and 3.
alved conduits from the ventricle to the pulmonary arteries (pulmo
conduit; PC) have a high failure and intervention rate in infants and 
children.1-3 Although a variety of PC types are available, the op
rosthesis choice for PC performance and patient outcome is unknown.1-7 The
ongenital Heart Surgeons Society (CHSS) undertook a multi-institutional, pro-
pective study to characterize PC durability and dysfunction as delineated by
chocardiography in children under age 2 years at initial implantation.
aterials and Methods
atients
rom 2002 to 2005, 241 children at 17 CHSS institutions were discharged alive after initial
C insertion at age less than 2 years and were enrolled in a prospective observational study.
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Dxclusion criteria included the following: non-biventricular 
airs, ventricular septal defect fenestration, PC placement with
entricular septal defect closure, or nonvalved conduits. This s
as approved by all institutional review boards and infor
arental consent was obtained. Patient characteristics and PC t
re given in Table EI.
ata Collection
ata abstracted by CHSS data center staff were obtained 
edical records for all admissions, operations, diagnostic 
nterventional catheterizations, echocardiograms, and autopsie
ross-sectional follow-up was performed between August 
eptember 2005 and was complete for 89% of the cohort. 
bstracted included patient and procedural characteristics, PC 
ures, allograft donor information, and longitudinal assessmen
C stenosis and regurgitation. Pulmonary artery and ventric
chocardiographic dimensions were converted into Z-scores 
egression equations based on previously published nomograms8,9
Catheter-based interventions and PC repairs were classifi
s PC-related, non–PC-related, pulmonary artery interventio
nd left heart interventions. Adjudication of PC and non–
elated interventions were made by panel review of diagnostic
rocedural reports. Study end points were first PC-related i
ention (catheterization or surgical) and conduit durability (time to
xplantation).
ata Analysis
ata are given as frequency, median with range, or mean 
tandard deviation as appropriate, with the number of nonmissing
alues indicated. All data analyses were performed with SAS
tatistical software (version 9.1; SAS Institute, Inc, Cary, NC).
nitial events, using PC implant date as time zero, were modeled as
ime-dependent events by using both Kaplan-Meier estimates and
arametric methods, with the association with risk factors being
xplored in multivariable parametric analysis as previously
escribed.10,11
Serial echocardiographic measurements obtained from reports
occurring before any PC intervention) of Doppler peak instanta-
eous PC gradient and subjective grade of PC regurgitation were
odeled, and risk factors were sought by using general linear
ixed regression models and general estimating equations. Uni-
ariable exploratory plots were generated initially to determine the
ongitudinal relationship (eg, linear, quadratic, cubic) between
ach potential predictor and outcome. Factors were then entered by
stepwise selection algorithm, with interaction terms added in a
ierarchical manner. For the mixed linear regression models, can-
idate covariance structures were tested explicitly with the final
Abbreviations and Acronyms
CHSS  Congenital Heart Surgeons Society
CI  confidence interval
JVV  jugular venous valved conduit
MAPCAmajor aortopulmonary collateral artery
PC  pulmonary conduitatrix selected on the basis of variograms and minimization of the d
30 The Journal of Thoracic and Cardiovascular Surgery ● Octoa
nformation criteria (AIC and BIC) generated from PROC MIXED.
C subjective regurgitation grade was modeled as an ordinal
utcome (graded as none, trivial, mild, moderate, or severe), and
he assumption of proportional odds was verified with cumulative
ogit plots. Time zero was taken to be the date of PC implant, so
hat only postoperative values and those occurring before any
C-related intervention (n  729) were used. However, preoper-
tive values (as time independent covariables) were investigated as
otential predictors in all models.
esults
here were 280 PCs placed in 241 patients during the study
eriod. Five patients have died, and 150 currently remain
ree of any PC-related intervention after initial PC place-
ent (Figure E1).
onduit-related Initial Interventions
f the 241 patients, 89 underwent a first intervention after
ischarge from the hospital; 63 interventions were catheter-
ased, 1 PC was surgically repaired, and 25 were explanted.
revalence of first PC intervention was 25% (70% confidence
ntervals (CIs): 23-27%) and 58% (70% CIs: 54-62%) at 1
nd 3 years, respectively, Figure 1. Initial intervent
ccurred frequently and at a constant hazard rate from initial
C implant.
onduit Explantation
here were 37 initial PCs explanted during the study
eriod; 25 explantations occurred without prior interven-
ion and 12 occurred after either a catheter-based proce-
igure 1. First conduit-related intervention after initial implan-
ation. Each symbol represents an intervention: vertical lines
re asymmetric confidence limits (CLs) equivalent to 1 stan-
ard error (68%); numbers in parentheses are children remain-
ng at risk; solid lines are parametric estimates enclosed in
ashed 68% CLs.ure or repair. Primary reasons for explantation included
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DC obstruction in 22 patients, regurgitation in 8, and
seudoaneurysm in 2 patients. Five patients underwent
xplantation as an incidental procedure. Prevalence of PC
xplantation was 7% (70% CIs: 6-8%) and 30% (70%
Is: 25-34%) at 1 and 3 years, respectively (Figure 
he risk of PC explantation was characterized by an
arly-rising risk, suggesting that catheter-based interven-
ion and PC repair are effective at prolonging PC lon-
evity by blunting this early risk (Figure 2).
eterminants of Conduit-related Initial Interventions
ncremental risk factors associated with an increased risk of
rst PC-related intervention included the presence of major
ortopulmonary collateral arteries (MAPCAs), right pulmo-
ary artery stenosis, smaller initial PC Z-score, younger age
t initial PC insertion, and the use of a proximal noncir-
umferential autologous pericardial extension (Table E
he relationship between initial PC Z-score and interven-
ion was nonlinear. Estimated risk-adjusted prevalence of
rst PC intervention at 2 years after implant is 100% when
he initial PC Z-score is less than 1, with no further
eduction in risk at initial PC Z-score greater than 1
Figure 3, A). Two specific solutions to the multivaria
quation for first intervention show the disparate outcome
or a child in whom a proximal noncircumferential exten-
ion with autologous pericardium was used compared with
igure 2. Instantaneous risk (hazard function) of first conduit-
elated intervention. There is an ongoing late hazard for conduit
xplantation (n  37) that eventually, at 4 years, exceeds the
onstant hazard for first conduit-related interventions (including
atheter-based events (n  63) and conduit reoperations (n 
6)). Catheter-based intervention and repair, therefore, are effec-
ive at prolonging conduit longevity by blunting the early rise in
isk and decreasing the prevalence of explantation within the
rst year after initial implantation. Solid curves are parametric
stimates enclosed within dashed 68% confidence limits.he outcome for a patient in whom either no proximal d
The Journal of Thoracic.igure 3. A, Risk-adjusted nomogram shows the relationship be-ween the initial pulmonary conduit Z-score and the prevalence
f first conduit-related intervention at 2 years from initial conduit
mplantation. The relationship is nonlinear, whereupon interven-
ion is universal for children whose initial PC Z-score was less
han 1.5, with a rapidly decreasing risk as the Z-score ap-
roaches 1. However, there is no further incremental reduction
n risk at conduit Z-scores greater than 1. Solid lines are
ontinuous parametric point estimates enclosed by dashed con-
dence limits equivalent to 1 standard error (68%). B, Risk-
djusted estimates of first conduit intervention for 2 different
atients on the basis of whether or not a proximal noncircumfer-
ntial extension with autologous pericardium was used. In A, the
ultivariable equation for first conduit intervention has been
olved for a patient with MAPCAs who undergoes initial conduit
lacement with the use of an ideally sized conduit (Z-score 
2) at age 2 months with the use of a pericardial extension. In B,
he multivariable equation has been solved for a patient with the
ame characteristics and initial conduit Z-score without proximal
xtension or use of material other than autologous pericardium.
or patient A, conduit reintervention is 60% at 1 year after initial
onduit insertion. In contrast, the prevalence of conduit reinter-
ention for patient B is only 25% at 1 year after initial conduit
mplant. Solid lines are parametric point estimates enclosed by
ashed confidence limits equivalent to 1 standard error (68%).
and Cardiovascular Surgery ● Volume 132, Number 4 831
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Dxtension was used or in whom the extension was con-
tructed with material other than autologous pericardium
Figure 3, B).
The relationship between age at initial PC placement and
rst PC-related intervention was also nonlinear. PC inter-
ention occurred earlier in the youngest patients, with a
apidly decreasing risk in children greater than 1 year of age
t initial PC placement (Figure 4, A). Two specific solution
o the multivariable equation for first intervention show the
isparate outcome for a patient with favorable characteris-
ics undergoing initial PC implantation at age 2 years com-
ared with the outcome for a patient with more favorable
haracteristics undergoing PC implantation as a neonate
Figure E3).
Risk of first PC intervention was independent of PC type
Figure E4), PC manufacturer, preparation technique 
luding decellularization), ABO blood-group mismatch, do-
or age or gender match, warm and cold ischemic times,
nd duration of cryopreservation.
eterminants of Conduit Explantation
ncremental risk factors associated with an increased risk of
C explantation were smaller Z-value for the right pulmo-
ary artery, bilateral pulmonary artery stenoses (surrogated
y bilateral pulmonary arterioplasties concomitant with ini-
ial PC placement), and smaller initial PC Z-score (T
2). PC explantation was also independent of PC 
igure 4. Risk-adjusted nomogram shows the relationship be-
ween the initial patient age and first conduit-related intervention
t 2 years after initial implant. Conduit interventions occur earlier
n younger patients, especially in those less than age 1 year at the
ime of initial conduit insertion. Solid lines are parametric point
stimates enclosed by dashed confidence limits equivalent to 1
tandard error (68%).Figure E5). o
32 The Journal of Thoracic and Cardiovascular Surgery ● Octoongitudinal Assessment of Conduit Function
erial echocardiographic measurements (n  729) were
ollected in 224 patients at a median interval of 2.6 months
ranging to 3.6 years) after initial PC insertion. The median
umber of echocardiograms per patient was 3 (range 1-13).
Progression of PC peak instantaneous gradient. Peak
oppler gradients (n  512) progressed nonlinearly in all
atients over time (P  .001; Figure 5, A). Gradient pro
ression was more rapid in children having aortic allo-
rafts than in those with all other conduit types (P  .01;
igure 5, B ). Peak gradients were higher at all time po
n those with proximal noncircumferential autologous peri-
ardial extension (P  .007, Table E3). The relationsh
etween initial PC Z-score and gradient progression was
omplex, whereupon children with initial PC Z-score less
han1 or greater than3 had more rapid progression than
hose with intermediate initial PC size (Figure 5, C).
Progression of PC regurgitation. Similarly, subjective
C regurgitation grade (n  552) progressed nonlinearly in
ll patients (P  .001; Figure 6, A). Factors associated wit
ore severe PC regurgitation across time included younger
ge at initial PC implant (P  .001) and larger initial PC
-score (P  .004; Table E3). Using quartiles of the in
C Z-score, we found that the upper 25%, corresponding to
Z-score greater than 3, was associated with more severe
egurgitation than was the lower 75% (Figure 6, B). A
ignificant time interaction existed for bovine jugular ve-
ous valved conduit type (JVV), whereby children with
VVs, despite having a higher initial grade of regurgitation,
ad a lower probability of subsequent progression to a more
evere regurgitation grade than did children with other PC
ypes (Figure E6). There was also a trend toward 
evere regurgitation in children having aortic allografts (P
.053), although statistical significance was not reached.
iscussion
his study is the first prospective, multi-institutional com-
arison of PC durability and function as delineated by
chocardiography among currently available PC types in
nfants and young children. We have shown that PC inter-
ention and explantation occur commonly and that echocar-
iographic progression of stenosis and regurgitation are
niversal when PC insertion is performed in those less than
years of age. Our results show that younger age at initial
C implant, the presence of pulmonary artery arborization
bnormalities, and an initial PC Z-score less than 1 in-
rease the risk of PC-related intervention and explantation.
e have determined, using our longitudinal echocardio-
raphic data, that an initial PC Z-score between 1 and 3
inimizes both peak gradient and regurgitation progression.
inally, although PC-related intervention was independent
f PC type, aortic allografts had more rapid peak gradient
ber 2006
p
r
o
v
c on
t
c
t
t
d
c
y
i
c
i
c lds
f
p
o
c
a
a
l
r
n
c
b
h
c
c
F
r
i
r
a
g
p
m
v
t
g
a
r
p
c
g
w
c
d
d
s
s
g
c
S
Karamlou et al Surgery for Congenital Heart Disease
CH
Drogression and also tended toward more severe grade of
egurgitation than did other PC types.
Previous studies have demonstrated the accelerated risk
f deterioration and replacement of valved conduits from a
entricle to the pulmonary arteries in neonates and small7
The Journal of Thoracichildren.1-3 These studies have largely concentrated 
hose factors associated with surgical reintervention and
onduit explantation, with relatively little information on
he prevalence of PC-sparing interventions and their role in
he extension of the functional life of these valved con-
uits. Our study demonstrates that approximately 40% of
hildren having initial PC insertion at age less than 2
ears will undergo an intervention within 2 years after PC
mplantation, with most of these interventions initially
atheter-based. The increased prevalence of percutaneous
ntervention after valved conduit implantation in our study
ompared with others12 is likely related to lower thresho
or catheter-based intervention in 2006 compared with a
rior era, as well as the complex pulmonary arterial anat-
my of children in our series. Importantly, we found that
atheter-based intervention and conduit repair are effective
t prolonging PC durability by blunting the initial early risk
ssociated with PC explantation. Although a potentially
ower threshold for catheter-based intervention than for PC
eplacement makes the true measure of PC durability and
eed for reoperation difficult to ascertain, certainly, if most
hildren had undergone PC explantation rather that catheter-
ased intervention, the prevalence of reoperation would
ave been much higher and reoperation would have oc-
urred much earlier. This supports the current initial use of
atheter-based interventions for PC-related obstruction and
igure 5. A, Echocardiographic Doppler peak gradient across the
ight ventricle–pulmonary artery conduit progressed nonlinearly
n all patients over time (P < .001). Gradient progression was
apid in the initial year after conduit implant and tapered there-
fter. Closed circles represent the mean value for the peak
radient for deciles of time; solid lines represent continuous
oint estimates from the mixed linear regression model. B, Esti-
ated echocardiographic Doppler peak gradient across the right
entricle–pulmonary artery conduit progression stratified by ini-
ial conduit Z-score. Quartiles of the initial conduit Z-score were
enerated. For clarity, the middle 2 quartiles were combined into
single intermediate group. Peak gradient progressed more
apidly in those patients within the lower 25th and upper 75th
ercentiles for initial conduit Z-score, indicating that oversizing
onduits beyond a Z-score of 3 may accelerate gradient pro-
ression. Geometric symbols represent the mean peak gradients
ithin each Z-score group per decile of time; solid lines are
ontinuous parametric estimates enclosed by dashed 70% confi-
ence limits. C, Estimated echocardiographic Doppler peak gra-
ient across the pulmonary conduit after initial conduit insertion
tratified by conduit type (aortic allograft vs non-aortic allograft)
hows that patients having aortic allografts had more rapid
radient progression (P < .001) than did patients with all other
onduit types after adjustment for other significant predictors.
olid lines are continuous point estimates enclosed by dashed
0% confidence limits.and Cardiovascular Surgery ● Volume 132, Number 4 833
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Dhat these interventions appear to delay the need for PC
xplantation.13-15
Despite the relatively short follow-up period, conduit
xplantation was undertaken in 20% of our patients up to 2
ears from initial implant. We demonstrated that younger
ge at initial PC placement and initial PC Z-score less than
1 are associated with an increased risk of first PC inter-
ention, emphasizing the importance of appropriately sizing
he PCs to maximize durability. Although many studies
ave shown that undersized PCs predispose to early PC
ailure,16-18 Wells,7 Karamlou,19 and their colleagues, re-
orted that placement of oversized PCs does not improve
urability even in young infants at high risk for somatic
utgrowth. Oversizing heterotopically placed PCs in certain
iagnostic subgroups (eg, L-transposition of the great arter-
es with pulmonary atresia) may further increase the risk of
ternal compression and reduce PC durability. However, we
id not find that either of these diagnostic subgroups was
ssociated with adverse outcome, and therefore a recom-
endation that PCs be further downsized in the presence
f these diagnoses would be speculative. Our longitudinal
chocardiographic analysis of PC function allowed further
lucidation of an ideal initial PC Z-score. We showed that
n initial PC Z-score between 1 and 3 minimizes both
eak gradient and regurgitation progression. On the basis of
his study, we recommend that a valve with a Z-score
etween 1 and 3 be used in children undergoing PC
nsertion at age less than 2 years.
Additionally, we found the presence of MAPCAs and right
ulmonary artery stenosis to be risk factors for PC-related
ntervention. The influence of pulmonary artery arborization
bnormalities underscores the role that increased pulmonary
rtery pressure and resistance may play in early PC deteri-
ration. Further, any technical or anatomic situation result-
ng in obstruction or high pressure within the PC could
otentially lead to earlier explantation. In support of this
ontention, the series by Heinemann and colleagues20 found
hat even a mild postoperative right ventricle–pulmonary
ressure gradient was a risk factor for PC replacement
ithin 2 years after repair of truncus arteriosus.
Our finding that autologous pericardial noncircumferen-
ial extensions contribute both to the need for PC interven-
ion and to more rapid peak gradient progression is puzzling
nd contrasts with the findings of others who have observed
hat expanded polytetraflouroethelyne21 and Dacron22 ex-
ensions confer an increased risk of intervention for relief of
C obstruction.
Importantly, we did not find PC type to be a risk factor
or either first PC intervention or explantation. However,
ur longitudinal echocardiographic assessment of conduit
unction demonstrated that aortic allografts had early devel-
pment of stenosis and tended to have earlier progression ofigure 6. A, The prevalence of more severe conduit regurgita-
ion, by subjective grade as determined by echocardiography,
ncreased nonlinearly over time. As time elapsed, the propor-
ion of patients having severe regurgitation increases dramat-
cally, with proportionally fewer patients remaining in lower
rdered grades. Solid lines are continuous point estimates and
how the proportion or each individual regurgitation grade
ver time. B, Risk-adjusted estimates of the proportion of pa-
ients that will exist in each subjective grade of regurgitation
ver time stratified by the 3 major conduit types. The graph
emonstrates the increased prevalence of both moderate and
evere regurgitation as more time elapses from initial conduit
lacement. The 3 solid lines at the top represent severe regurgi-
ation; the 3 middle dashed lines represent moderate regurgita-
ion, and the bottom 3 solid lines represent mild or less regurgi-
ation. Patients with JVV conduits had a significantly lower
robability of being in a higher ordered grade of regurgitation
han did others, and children having initial aortic allografts
ended to have a higher probability of having more severe regur-C regurgitation after adjustment for other factors. Early
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Deterioration and failure of aortic allografts has been re-
orted by others,1,13,23,24 but it has previously been diffic
o determine whether this was due to an inherent disadvan-
age of the aortic allograft or due to other confounding
atient-related factors. Conversely, JVVs had less progres-
ion of regurgitation than did other PC types despite higher
nitial regurgitation grade. Early favorable hemodynamics
ere similarly reported by Carrel,24 Breymann,25 and their
olleagues, with the use of JVVs. Potential reasons for im-
roved hemodynamic performance may be related to obviation
f the need for proximal extension hoods and their associated
dditional suture lines with JVVs, or potentially more favor-
ble handling characteristics compared with other PC types.
he ability to tailor JVVs also may facilitate more distal
osition of the valve, thereby avoiding compression by the
ternum. The wider availability of JVVs makes their use in
nfants even more attractive owing to the relative scarcity of
mall allograft valves. Longer-term follow-up is needed to
etermine whether early differences in PC function as delin-
ated by echocardiography will translate into improved PC
urability.
The finding that porcine heterografts were not associated
ith decreased PC durability in these young children was
nexpected. Our experience with porcine xenografts was
uite favorable, but limited with only 5 patients, precluding
ecommendations based on our results. Porcine valved Da-
ron conduits have been shown by others to require earlier
ntervention than allografts.17,26 In contrast, Dearani an
olleagues27 reported that porcine heterografts and porcin
alved Dacron conduits were more durable than allografts.
ewer technology fixation techniques applied to aortic bio-
rostheses may allow better porcine valved conduits in
maller sizes in the future.
tudy Limitations
here are several limitations to this large, multi-institutional
tudy. We acknowledge that it is nearly impossible to ex-
mine carefully different valve types and the risk factors for
C failure outside the scope of a randomized trial. Tech-
iques of PC implantation and criteria for intervention and
eplacement were not standardized and therefore are auto-
atically variable. Absence of protocolized echocardio-
raphic review is another important limitation. Valve types
ere not uniform in number, with allografts predominating
nd JVVs and decellularized allografts less commonly and
ore recently used. Follow-up in this series is relatively
hort, even though a large number of events did occur
uring the time period examined.
onclusions
election of a valved conduit with a Z-score between 1 to
3 at initial implantation allows optimal PC durability inhis difficult-to-treat group of infants and young children.
The Journal of Thoracicnitial intervention with catheter-based techniques and sur-
ical repair are advantageous in reducing PC failure. Aortic
llografts have inferior PC function on early echocardiographic
xamination, but longer follow-up is needed to determine
hether this will translate into decreased PC longevity.28
We are grateful to the members of the Pulmonary Conduit
orking Group: Christo I. Tchervenkov, MD, Montreal, Quebec,
anada; David M. Overman, MD, Minneapolis, Minn; Thomas
eh, Jr, MD, PhD, Dallas, Tex; Jeffrey P. Jacobs, MD, St. Peters-
urg, Fla; Linda M. Lambert, RN, Salt Lake City, Utah. These
ndividuals assisted in data verification, analysis, and manuscript
reparation. We are grateful for the assistance of personnel from
he CHSS Data Center, particularly Geraldine Cullen-Dean, Sally
ai, Haddas Grosbein, and Candice Cumberbach, for coordinating
he collection and management of these data. We thank all the
embers of the CHSS and their pediatric cardiology colleagues for
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iscussion
r Joseph A. Dearani (Rochester, Minn). I have no disclosures.
I would like to congratulate Dr Karamlou, the coauthors, and
he participating members of the CHSS for this outstanding pre-
entation and important contribution on the results of extracardiac
onduits in infants and young children. This group of patients
ontinues to present difficult challenges to interventional cardiol-
gists and surgeons, since reinterventions are eventually required
n all patients. The manuscript is well written and the analysis is
etailed and comprehensive in the usual Blackstone fashion.
It has been 42 years since Dr Kirklin placed the first conduit
uring repair of pulmonary atresia in a 6-year-old child. Advances
n neonatal intensive care unit care and advances in neonatal
urgical techniques, including those that use a conduit, have re-
ulted in successful repair of very complex lesions during infancy.
Importantly, this study is the first prospective, multi-institutional
omparison of PC durability and function as delineated by echo- t
36 The Journal of Thoracic and Cardiovascular Surgery ● Octoardiography among currently available PCs in infants and young
hildren. Conduits used included pulmonary and aortic homografts
nd bovine JVV grafts. The authors’ main conclusion was that
onduit durability and hemodynamic function were improved by
sing larger conduits, that is, conduits upsized with Z-scores
etween 1 and 3.
Another critically important finding noted in this review was
hat the durability of the bovine JVV graft was comparable with
hat of the homograft, which has been the conduit of choice in
nfants and small children. Given the limited availability of ho-
ografts in small sizes, this issue is of practical importance to the
urgeon when dealing with the infant, since the handling charac-
eristics of the bovine graft are quite favorable and there is greater
vailability in smaller sizes.
Although these children were followed prospectively, it is
mportant to note that the study was nonrandomized. The authors
ave identified a poorer outcome in aortic homografts and a trend
f a greater degree of regurgitation in aortic homografts. We and
thers have demonstrated that aortic homografts are more likely to
ave minimal regurgitation early after operation than are pulmo-
ary homografts. As such, in this nonrandomized study, surgeons
ay have preferred the aortic homograft when the anticipated
ulmonary artery and right ventricular pressures were going to be
levated at the end of the operation.
My first series of questions is on this topic. Was there a
orrelation between conduit type and durability while factoring
ight ventricular pressure at the end of operation? That is, do you
hink there was a selection bias and that the greater degree of
egurgitation seen in the aortic homografts was due to these factors
s opposed to the type of conduit?
Dr Karamlou. I think that the answer to your question is no.
lthough our catheter data were somewhat opportunistic in that we
sually retrieved catheterization data according to interventions, I
an say that we did look at right ventricular pressures, we did look
t mean pulmonary artery pressures, and there was no significant
ifference among conduit types regarding those hemodynamic
easures. Although we cannot say for certain, because the study
as nonrandomized and therefore the indications for specific con-
uit types were variable, I think that, as best as we could have done
n the nonrandomized study, we did look at hemodynamics and it
as not an important variable that affected either the selection of
ach conduit type nor the outcome.
Dr Dearani. With that in mind, which conduit would you use,
he bovine JVV graft, if you expect the right ventricular pressure
o be elevated at the end of the operation?
Dr Karamlou. On the basis of the data that we have shown
oday, there probably is no benefit to using an aortic allograft even
n those patients. As you noted from the risk-adjusted model,
ulmonary artery arborization anomalies did fall out as significant
redictors; therefore, after adjusting for these particular unfavor-
ble morphologic characteristics, still there was no impact of
onduit type. So I’d have to say yes.
Dr Dearani. We have also learned from the surgical literature
hat right ventricle–pulmonary artery conduits placed in the ortho-
opic position, for example, in patients with tetralogy-like anat-
my, are more durable because of a more natural anatomic posi-
ion, compared with conduits placed in the heterotopic position, for
ber 2006
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Dxample, transposition and truncus. This issue becomes important
hen upsizing the conduit.
Heterotopic conduit placement is more susceptible to compres-
ion with sternal closure. Patients most at risk would be those with
ransposition or truncus. Was chest closure a problem in any of
hese patients? What are your recommendations about not over-
izing the conduit too much when these particular diagnoses are
eing factored into the equation?
Dr Karamlou. In a large proportion of infants, the chest was
ot closed after the initial conduit placement. We did look at
hat we termed non– conduit-related procedures as a risk fac-
or, and this did not fall out as a risk factor for conduit durability,
lthough we did not look at morbidity or survival because those
ere not end points examined in the study. So I cannot specifically
nswer your question regarding sternal closure as a potential
eterminant of morbidity. However, I still think it is very im-
ortant not to oversize the conduit. This is especially crucial,
or instance, in corrected transposition or other morphologic
ypes, when the conduit may be either in a very adverse position
r directly underneath the sternum. I think especially in those
ases, you want to avoid oversizing because that can lead to
ternal compression, kinking, and perhaps an accelerated risk of
tenosis.
Dr Dearani. Finally, it was interesting that a noncircumferen-
ial pericardial hood was a risk factor for reintervention. In our
xperience, a nonpericardial hood was more problematic. How-
ver, when a pericardial hood was used, it did not matter whether
t was circumferential or noncircumferential, the obstruction al-
ost always occurred at the valvular level of these homografts.
ould you comment on this?
Dr Karamlou. We were very surprised by the finding that
utologous pericardium was a risk factor both for conduit inter-
ention and for an accelerated risk of gradient progression. We are
ware of your results showing exactly the opposite.
I can say that it is potentially confounded by the fact that this
ell out as a risk factor against all other things, including not
lacing a proximal extension of any kind. It could very well be that
hat we are really detecting is that it is more favorable to avoid
ny kind of proximal extension with its attendant additional suture
ines, and that could be the reason that we are seeing this as a risk
actor.
Dr Vaughn A. Starnes (Los Angeles, Calif ). I am having a real
roblem with the idea that this autologous extension is a risk
actor. What I think I understand you to say is that this is a group
f heterotopically placed conduits. Did you analyze that as a
eparate multivariate analysis? When you look at pericardial ex-
ension versus heterotopic placement, does it still fall out as a risk
actor?
Dr Karamlou. We did look at orthotopicity, and actually there
s really a spectrum of orthotopicity. We looked at just the Ross
rocedures as being the purest form of orthotopic placement versus
hose with maybe less orthotopicity being the 10 absent valve
atients, and none of those things came out as favorable factors
hat obviated the need for conduit intervention.
All I can say is that we are surprised at this and it probably
equires further study. Regardless of all of those other factors, it
till was a very strong determinant of both of those end points. i
The Journal of ThoracicDr Scott M. Bradley (Charleston, SC). Were proximal hoods
ade of other material used frequently enough that you could say
hat those other materials were not risk factors?
Dr Karamlou. Yes, with the exception probably of xenograft
ericardium, all of the different types, including synthetic material,
ortic pulmonary homograft, and what we termed unspecified
omograft whose composition could not be precisely documented,
think that those were populated enough that we could look at
hose types of things as risk factors.
Again, it is difficult to sort out. Is it that the autologous pericar-
ium was used in cases where the conduit was heterotopic? Was it
hat larger initial Z-scores are confounded with hood placements?
It is sometimes a little bit difficult to ascertain exactly which things
re truly related to outcome with this type of multicollinearity.
Dr Antonio F. Corno (Liverpool, United Kingdom). The ob-
truction of a right ventricle–pulmonary artery conduit can well be
ue to the fact that the patient is outgrowing the conduit, particu-
arly when you consider patients between 6 and 24 months of age,
hen there is the most important growth of body surface area and
hen you can implant a relatively small-sized conduit. But it can
lso be due to, or can be increased by, technical complications.
Did you try to analyze whether the pressure gradient was all
long the conduit, or, in certain cases, was mainly localized at the
evel of the proximal anastomosis or at the level of the distal
nastomosis?
Dr Karamlou. Yes, we did. In fact, all of the members of the
orking group tried, through adjudication, to determine what was
he predominant reason for conduit placement—was it somatic
utgrowth, was it valvular, was it diffuse, was it distal? We tried
s best as we could, from again. Most of the material can be really
ooked at objectively through cardiac catheterization data, which
e did not have a full composite of over the time period. Again,
ost of these things were obtained at the time of intervention. As
his cohort matures (this study was just initiated in 2002), we hope
o accrue more patients and to look at cardiac catheterizations in a
ore nonbiased way. Potentially we can answer your question
ore precisely.
Dr John E. Mayer, Jr (Boston, Mass). Having contributed a
air number of these conduits, I’m sure, I guess my concern reflects
little bit of what Dr Dearani was talking about: certainly if there
ere situations in which we anticipated that the distal pulmonary
rtery pressures were going to be elevated or there was going to be
igh impedance or resistance to pulmonary blood flow, I would, by
reference, have chosen an aortic homograft as opposed to a
ulmonary homograft, for instance. I think there is some clue that
hat is what is going on because of the impact of this pulmonary
rtery arborization as being also associated with an earlier failure
ate or earlier reintervention.
How it is that you are able to separate out the factor interactions
hat you have identified through your multiple logistic regression?
econd, is there not additional work that might need to be done to
ake sure that somehow or another these factors are not, in fact,
nteracting?
Dr Karamlou. Your first question certainly does require fur-
her study, and that’s why the study is ongoing. We hope that you
ll will continue to send your patients so that we can answer these
mportant questions.
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DIt was a comprehensive data set and we did consider all
nteractions, including those with hemodynamic parameters and
pecific conduit types. As you are no doubt aware, as you
ntroduce more variables, you run into an overspecified model
ith a small number of events. That’s why we tried to use our
ongitudinal analysis to get around some of these potential type38 The Journal of Thoracic and Cardiovascular Surgery ● OctoFrom a nonrandomized study with a small number of patients
er institution, we cannot reliably control for institutional bias
avoring aortic allografts in patients with unfavorable morphology
r propensity toward regurgitation. However, if you look at the full
odel that we fit, pulmonary artery arborization abnormalities
ere significant predictors of conduit failure while conduit typeerrors or power-related errors. was not.
Online—www.aats.org
Now you can get  online. 
The Journal online brings you faster delivery time, easy searching of current and 
back issues, links to PubMed, AATS, WTSA, and other important sites, and more. 
Visit the Journal online today.
Receive tables of contents by e-mail
To receive the tables of contents by e-mail, sign up through our Web site at
Choose 
Simply type your e-mail address in the box and click the  button.
You will receive an e-mail to confirm that you have been added to the mailing 
list.
Note that TOC e-mails will be sent out when a new issue is posted to the Web site.
The Journal of Thoracic and Cardiovascular Surgery
Subscribe
E-mail Notification
http://journals.elsevierhealth.com/periodicals/ymtcber 2006
Figure E1. Outcomes of children receiving first valved ventricle–pulmonary artery conduit. Note that there were 4
patients who had a second conduit reoperation (1 repair and 3 replacements). Thus, in total, there were 280
conduits placed in 241 patients during the study period. Five patients have died, and 150 patients currently remain
free of any conduit-related intervention after their initial conduit placement. Three patient deaths were related to
conduit intervention (although not related to conduit failure per se) and 2 were unrelated, occurring at 6 weeks
and 17 months after initial conduit implant.
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TABLE E1. Patient and initial pulmonary conduit characteristics (n  241)
Variable Value No. missing
Demographic characteristics
Gender (female/male) 124:117 0
Age at conduit implant (median with range) 1.4 m (0-1.95 y) 0
Weight at conduit implant (kg, mean, SD) 4.8 2.5 5
Previous surgical procedure 88 (37%) 0
Morphologic characteristics
Primary cardiac diagnosis 0
Truncus arteriosus 88 (36%)
Pulmonary atresia/VSD 69 (29%)
Aortic valve stenosis/regurgitation 19 (8%)
TGA with atrioventricular concordance 16 (7%)
Double-outlet right ventricle 15 (6%)
ToF with absent pulmonary valve 14 (6%)
Interrupted aortic arch 7 (2%)
TGA with atrioventricular discordance 6 (2%)
ToF 5 (2%)
Other 2 (1%)
Major associated cardiac anomalies 0
None 73 (30)
Right aortic arch 48 (19%)
Left ventricular outflow tract obstruction 30 (12%)
Major aortopulmonary collateral areries 30 (12%)
Left superior vena cava 24 (10%)
Atrioventricular valve anomaly 14 (6%)
Ductal origin of a distal pulmonary artery 10 (4%)
Coronary artery anomalies 4 (1%)
RPA stenosis at pre-conduit echocardiogram 43 (25%) 69
LPA stenosis at pre-conduit echocardiogram 42 (25%) 70
Initial conduit features
Type of conduit 0
Pulmonary allograft 89 (37%)
Aortic allograft 71 (16%)
Bovine jugular venous valved 60 (25%)
Decellularized pulmonary allograft 9 (4%)
Decellularized aortic allograft 7 (3%)
Porcine heterograft 5 (2%)
Size of conduit (mm, mean  SD) 12 2 0
Z-score of conduit (median and range) 1.8 (1.5 to 4.6) 5
Proximal extension used 133 (55%) 0
Noncircumferential 122 (51%)
Circumferential 11 (5%)
Proximal extension material 0
Allograft 47 (35%)
PTFE/Dacron 36 (27%)
Autologous pericardium 35 (26%)
Xenograft pericardium 15 (11%)
Concomitant procedures at conduit implant 0
LPA arterioplasty 35 (15%)
RPA arterioplasty 25 (10%)
Bilateral pulmonary artery arterioplasty 16 (7%)
Unifocalization 29 (12%)
ASD fenestration or intentional incomplete closure 80 (33%)
Konno aortoventriculoplasty 14 (6%)
Delayed sternal closure after initial conduit implantation 75 (31%) 0
Surgery for Congenital Heart Disease Karamlou et al
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TABLE E1. Continued
Variable Value No. missing
Factors specific for cryopreserved allografts
Warm ischemic time (h, median with range) 11.2 (0.01-49) 42
Total cryopreservation period (y, median with range) 0.74 (0.09-4.2) 35
ABO-blood group incompatible 39 (60%) 111
Gender mismatch 8 (46%) 0
n, Number; m, months; y, years; kg, kilograms; SD, standard deviation; mm, millimeters; h, hours; TGA, transposition of the great arteries; ToF, tetralogy of
Fallot; ASD, atrial septal defect; VSD, ventricular septal defect; LPA, left pulmonary artery; RPA, right pulmonary artery; PTFE, polytetrafluoroethylene.
Figure E2. Conduit explantation. Each symbol represents an ex-
plantation; vertical lines are asymmetric confidence limits (CLs)
equivalent to 1 standard error (68%); numbers in parentheses are
children remaining at risk; solid lines are parametric estimates
enclosed in dashed 68% CLs.
TABLE E2. Incremental risk factors for first conduit-related intervention and explantation
Variable Parameter estimate (SE) P value Reliability* (%)
1. For first conduit-related intervention
Younger age at initial PC implantation (per 1 year)† 0.49 0.20 .001 77%
Smaller initial PC Z-score‡ (per 1 unit) 0.15 0.03 .001 83%
RPA stenosis documented on echocardiogram before PC insertion 0.94 0.30 .002 64%
MAPCAS 1.08 0.29 .001 57%
Use of noncircumferential proximal extension with autologous pericardium 1.12 0.30 .001 81%
2. For conduit explantation
Smaller initial PC Z-score‡ (per 1 unit) 0.32 0.12 .009 78%
Smaller RPA Z-score documented on echocardiogram before PC insertion§ 0.001 0.003 .008 69%
Bilateral PA arterioplasty at time of initial PC implant 1.38 0.45 .002 64%
SE, Standard error; PC, pulmonary conduit; RPA, right pulmonary artery; MAPCAs, major aortopulmonary collateral arteries; PA, pulmonary artery. *Percent
(%) refers to the reliability determined by bootstrap bagging (1000 dataset resampling) method. †After square transformation. ‡Complex polynomial term
consisting of the inverse of the exponentiated term followed by square transformation. §After inverse transformation.
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Figure E3. Two specific solutions to the multivariable equation
for first conduit intervention show the influence of the age at
initial implant on the rate intervention at 2 years after initial
implantation. For a patient undergoing initial conduit implant at 2
years of age with an initial PC Z-score of 2, with favorable
pulmonary arterial anatomy and no conduit extension or use of
material other than autologous pericardium for the extension,
conduit intervention is below 20% even at 4 years after initial
implant. However, for a patient with pulmonary arterial arboriza-
tion abnormalities undergoing initial conduit implant in the neo-
natal period with the use of an undersized conduit and an autol-
ogous pericardial extension hood, of the predicted prevalence of
conduit-related intervention within 1 year of initial conduit im-
plantation is 100%. Solid lines are parametric point estimates
enclosed by dashed confidence limits equivalent to 1 standard
error (68%). MAPCAs, Major aortopulmonary collateral arteries;
RPA, right pulmonary artery.
Figure E4. Kaplan-Meier estimated freedom from first conduit-
related intervention stratified by conduit type. Freedom from first
intervention was not significantly related to the type of initial
conduit (P  .92; Wilcoxon), although follow-up intervals are
short for some of the conduit types. N is the number of patients
beginning within each stratum, and the numbers in parentheses
are the number of children remaining at risk at the last event-time
within 3 years of follow-up.
Figure E5. Kaplan-Meier estimated freedom from conduit explan-
tation stratified by conduit type. Freedom from explant was not
significantly related to the type of initial conduit (P  0.81;
Wilcoxon), although follow-up intervals are short for some of the
conduit types. N is the number of patients beginning within each
stratum, and the numbers in parentheses are the number of
children remaining at risk at the last event-time within 3 years of
follow-up.
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TABLE E3. Factors associated with longitudinal changes in conduit function
Variable Parameter estimate (SE) P
1. Increased PC peak Doppler gradient
Longer time interval from initial PC* 30.75 4.46 .001
Smaller initial PC Z-score† 1.79 0.57 .002
Use of an aortic allograft‡ 15.91 6.17 .01
Use of a proximal noncircumferential autologous pericardial extension 6.47 2.71 .007
2. Higher grade of PC regurgitation
Longer time interval from initial PC§ 0.46 0.05 .001
Younger age at initial PC implant 1.55 0.27 .001
Larger initial PC Z-score 0.02 0.01 .004
Non-use of a bovine jugular venous valved conduit‡ 0.80 0.26 .002
Use of an aortic allograft‡ 0.55 0.27 .053
SE, Standard error; PC, pulmonary conduit. *After inverse transformation. †Complex polynomial term consisting of the inverse of the exponentiated term
followed by square transformation. ‡Interaction term between conduit type and time; robust standard-errors using sandwich estimator are reported as
cluster size  200. §After logarithmic transformation. After exponential transformation.
Figure E6. Risk-adjusted estimates of the proportion of patients
who will exist in each subjective grade of regurgitation over time
stratified by quartiles of the initial conduit Z-score. For clarity, the
middle 2 quartiles have been condensed into a single group. The
largest upper 75% quartile, corresponding to a median initial
conduit Z-score of 3, was associated with more rapid progres-
sion to a more severe grade of conduit regurgitation after adjust-
ment for other predictors.
TABLE E4. List of participating institutions
The Children’s Hospital at Boston
Children’s Memorial, Chicago
Children’s Hospital of Michigan
Children’s Hospital of Philadelphia
Children’s Hospital and Health Center, San Diego
Children’s Hospital Wisconsin
Children’s Mercy Hospital, Kansas City
Dupont Hospital for Children
The Emory Clinic
The Hospital for Sick Children, Toronto
Mott Children’s Hospital
Milton Hershey Medical Center
Montreal Children’s Hospital
Doernbecher Children’s Hospital, Oregon Health Sciences
University
Primary Children’s Hospital
University of Chicago
University of Louisville
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